Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)

ClinicalTrials.gov ID: NCT01834638

Public ClinicalTrials.gov record NCT01834638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855

Study identification

NCT ID
NCT01834638
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
268 participants

Conditions and interventions

Conditions

Interventions

  • ABT-126 Drug

Drug

Eligibility (public fields only)

Age range
20 Years to 66 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2013
Primary completion
Oct 31, 2014
Completion
Oct 31, 2014
Last update posted
May 1, 2018

2013 – 2014

United States locations

U.S. sites
27
U.S. states
7
U.S. cities
26
Facility City State ZIP Site status
Site Reference ID/Investigator# 95398 Chino California 91710
Site Reference ID/Investigator# 95381 Costa Mesa California 92626
Site Reference ID/Investigator# 95400 Escondido California 92025
Site Reference ID/Investigator# 95406 Garden Grove California 92845
Site Reference ID/Investigator# 95378 National City California 91950
Site Reference ID/Investigator# 95390 Norwalk California 90650
Site Reference ID/Investigator# 95386 Oakland California 94612
Site Reference ID/Investigator# 95391 Oceanside California 92056
Site Reference ID/Investigator# 95380 Orange California 92868
Site Reference ID/Investigator# 95395 Pico Rivera California 90660
Site Reference ID/Investigator# 95403 Riverside California 92506
Site Reference ID/Investigator# 128356 San Bernardino California 92408
Site Reference ID/Investigator# 95405 San Diego California 92102
Site Reference ID/Investigator# 95397 San Diego California 92103
Site Reference ID/Investigator# 95384 San Gabriel California 91776
Site Reference ID/Investigator# 95385 Santa Ana California 92705
Site Reference ID/Investigator# 95387 Torrance California 90502
Site Reference ID/Investigator# 95382 New Haven Connecticut 06519
Site Reference ID/Investigator# 95399 Atlanta Georgia 30308
Site Reference ID/Investigator# 95377 Marietta Georgia 30060
Site Reference ID/Investigator# 120595 Chicago Illinois 60640
Site Reference ID/Investigator# 129380 Hoffman Estates Illinois 60169
Site Reference ID/Investigator# 95379 Cedarhurst New York 11516
Site Reference ID/Investigator# 95392 Rochester New York 14623
Site Reference ID/Investigator# 95388 Philadelphia Pennsylvania 19139
Site Reference ID/Investigator# 95402 DeSoto Texas 75115
Site Reference ID/Investigator# 95393 Houston Texas 77008

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01834638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2018 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01834638 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →